MedPath

Sentinel Lymph Node Detection Using Fluorescein Dye in Breast Cancer

Not Applicable
Completed
Conditions
Neoplasms
Registration Number
KCT0002377
Lead Sponsor
Korea University Ansan Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
61
Inclusion Criteria

Patients with breast cancer who needs sentinel lymph node biopsy during operation

Exclusion Criteria

1. Patients who does not need sentinel lymph node biopsy because of biopsy proven metastatic lymph nodes
2. Any medical condition or prior therapy that, in the opinion of the investigator, would make the subject unsuitable for this study
3. Hypersensitivity to fluorescein solution
4. Having a heart condition, feeling chest pain during physical activity, experiencing chest pain, becoming dizzy/ever losing
balance or consciousness
5. Being pregnant or breastfeeding
6. Having a general weakness

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detection rate of sentinel lymph nodes when using 10% Fluorescein and Technetium 99m sulfurcolloid
Secondary Outcome Measures
NameTimeMethod
Correlation between brightness of sentinel lymph nodes dyed by 10% fluorescein and radioactive score of technetium 99m sulfurcolloid, side effects
© Copyright 2025. All Rights Reserved by MedPath